BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35203608)

  • 1. Targeting PTB for Glia-to-Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases.
    Contardo M; De Gioia R; Gagliardi D; Comi GP; Ottoboni L; Nizzardo M; Corti S
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Potential of PTB Inhibition Through Converting Glial Cells to Neurons in the Brain.
    Fu XD; Mobley WC
    Annu Rev Neurosci; 2023 Jul; 46():145-165. PubMed ID: 37428606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical examination of Ptbp1-mediated glia-to-neuron conversion in the mouse retina.
    Xie Y; Zhou J; Chen B
    Cell Rep; 2022 Jun; 39(11):110960. PubMed ID: 35705044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutically viable generation of neurons with antisense oligonucleotide suppression of PTB.
    Maimon R; Chillon-Marinas C; Snethlage CE; Singhal SM; McAlonis-Downes M; Ling K; Rigo F; Bennett CF; Da Cruz S; Hnasko TS; Muotri AR; Cleveland DW
    Nat Neurosci; 2021 Aug; 24(8):1089-1099. PubMed ID: 34083786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice.
    Zhou H; Su J; Hu X; Zhou C; Li H; Chen Z; Xiao Q; Wang B; Wu W; Sun Y; Zhou Y; Tang C; Liu F; Wang L; Feng C; Liu M; Li S; Zhang Y; Xu H; Yao H; Shi L; Yang H
    Cell; 2020 Apr; 181(3):590-603.e16. PubMed ID: 32272060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Potential of PTBP1 Inhibition, If Any, Is Not Attributed to Glia-to-Neuron Conversion.
    Wang LL; Zhang CL
    Annu Rev Neurosci; 2023 Jul; 46():1-15. PubMed ID: 36750409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo glia-to-neuron conversion: pitfalls and solutions.
    Wang LL; Zhang CL
    Dev Neurobiol; 2022 Jul; 82(5):367-374. PubMed ID: 35535734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal conversion from glia to replenish the lost neurons.
    Liang S; Zhou J; Yu X; Lu S; Liu R
    Neural Regen Res; 2024 Jul; 19(7):1446-1453. PubMed ID: 38051886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lineage tracing of direct astrocyte-to-neuron conversion in the mouse cortex.
    Xiang Z; Xu L; Liu M; Wang Q; Li W; Lei W; Chen G
    Neural Regen Res; 2021 Apr; 16(4):750-756. PubMed ID: 33063738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in neuronal reprogramming for neurodegenerative diseases: Strategies, controversies, and opportunities.
    Li ST; Wan Y; Chen L; Ding Y
    Exp Neurol; 2024 Aug; 378():114817. PubMed ID: 38763354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential neuronal reprogramming induced by NeuroD1 from astrocytes in grey matter
    Liu MH; Li W; Zheng JJ; Xu YG; He Q; Chen G
    Neural Regen Res; 2020 Feb; 15(2):342-351. PubMed ID: 31552908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits.
    Xue Y; Ouyang K; Huang J; Zhou Y; Ouyang H; Li H; Wang G; Wu Q; Wei C; Bi Y; Jiang L; Cai Z; Sun H; Zhang K; Zhang Y; Chen J; Fu XD
    Cell; 2013 Jan; 152(1-2):82-96. PubMed ID: 23313552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTB-AS, a Novel Natural Antisense Transcript, Promotes Glioma Progression by Improving PTBP1 mRNA Stability with SND1.
    Zhu L; Wei Q; Qi Y; Ruan X; Wu F; Li L; Zhou J; Liu W; Jiang T; Zhang J; Yin B; Yuan J; Qiang B; Han W; Peng X
    Mol Ther; 2019 Sep; 27(9):1621-1637. PubMed ID: 31253583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-Directed Neuronal Reprogramming as a Therapeutic Strategy for Neurological Diseases.
    Faravelli I; Corti S
    Mol Neurobiol; 2018 May; 55(5):4428-4436. PubMed ID: 28664454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-124-9-9* potentiates Ascl1-induced reprogramming of cultured Müller glia.
    Wohl SG; Reh TA
    Glia; 2016 May; 64(5):743-62. PubMed ID: 26732729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTB/nPTB: master regulators of neuronal fate in mammals.
    Hu J; Qian H; Xue Y; Fu XD
    Biophys Rep; 2018; 4(4):204-214. PubMed ID: 30310857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Regulation of Glial Phenotypes: Implications in Neuron-Glia Interactions and Neurological Disorders.
    Afridi R; Kim JH; Rahman MH; Suk K
    Front Cell Neurosci; 2020; 14():20. PubMed ID: 32116564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ direct reprogramming of astrocytes to neurons via polypyrimidine tract-binding protein 1 knockdown in a mouse model of ischemic stroke.
    Yuan M; Tang Y; Huang T; Ke L; Huang E
    Neural Regen Res; 2024 Oct; 19(10):2240-2248. PubMed ID: 38488558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17.
    Yang Y; Yang S; Guo J; Cui Y; Tang B; Li XJ; Li S
    J Neurosci; 2017 Sep; 37(38):9101-9115. PubMed ID: 28821675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain repair from intrinsic cell sources: Turning reactive glia into neurons.
    Torper O; Götz M
    Prog Brain Res; 2017; 230():69-97. PubMed ID: 28552236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.